FDA ANTIBIOTIC REGULATION REPEAL WORKING GROUP CO-CHAIRED BY LUMPKIN, JOHNSTON; AGENCY TO MEET WITH PhRMA, GENERICS TRADE GROUPS ON PEDIATRIC EXCLUSIVITY

FDA's antibiotic regulation repeal working group is compiling a list of "old" antibiotics that will not be eligible for patent or exclusivity protection in the future, Office of Generic Drugs Deputy Director Gordon Johnston told the National Association of Pharmaceutical Manufacturers Feb. 3 in Puerto Rico.